Kenacort® Retard is a corticosteroid (cortisone-like medicine or steroid), which is commonly used to treat following medical conditions, such as:
Kenacort® Retard is given to patients who are not able to take medicines by the mouth. It may be prescribed for other uses; ask your doctor or pharmacist for more information.
This medicine is administered only by or under the immediate supervision of your doctor.
Kenacort® Retard is best stored at room temperature away from direct light and moisture. To prevent drug damage, you should not store Kenacort® Retard in the bathroom or the freezer. There may be different brands of Kenacort® Retard that may have different storage needs. It is important to always check the product package for instructions on storage, or ask your pharmacist. For safety, you should keep all medicines away from children and pets.
You should not flush Kenacort® Retard down the toilet or pour them into a drain unless instructed to do so. It is important to properly discard this product when it is expired or no longer needed. Consult your pharmacist for more details about how to safely discard your product.
Consult with your doctor or pharmacist, if:
There are no adequate studies in women for determining risk when using this medication during pregnancy or while breastfeeding. Please always consult with your doctor to weigh the potential benefits and risks before taking this medication. This medication is pregnancy risk category C, according to the US Food and Drug Administration (FDA).
FDA pregnancy risk category reference below:
Kenacort® Retard may cause following side effects, such as:
Not everyone experiences these side effects. There may be some side effects not listed above. If you have any concerns about a side-effect, please consult your doctor or pharmacist.
Kenacort® Retard may interact with other drugs that you are currently taking, which can change how your drug works or increase your risk for serious side effects. To avoid any potential drug interactions, you should keep a list of all the drugs you are using (including prescription drugs, nonprescription drugs, and herbal products) and share it with your doctor and pharmacist. For your safety, do not start, stop, or change the dosage of any drugs without your doctor’s approval.
Some products that may interact with this drug include:
Kenacort® Retard may interact with food or alcohol by altering the way the drug works or increase the risk for serious side effects. Please discuss with your doctor or pharmacist any potential food or alcohol interactions before using this drug.
Kenacort® Retard may interact with your health condition. This interaction may worsen your health condition or alter the way the drug works. It is important to always let your doctor and pharmacist know all the health conditions you currently have.
These health conditions are:
The information provided is not a substitute for any medical advice. You should ALWAYS consult with your doctor or pharmacist before using this medication.
Systemic
The suggested initial dose is 60 mg, injected deeply into the gluteal muscle. Atrophy of subcutaneous fat may occur if the injection is not properly given. Dosage is usually adjusted within the range of 40 mg to 80 mg, depending upon patient response and duration of relief. However, some patients may be well controlled on doses as low as 20 mg or less.
Hay fever/pollen asthma: Patients with hay fever or pollen asthma who are not responding to pollen administration and other conventional therapy may obtain a remission of symptoms lasting throughout the pollen season after a single injection of 40 mg to 100 mg.
In the treatment of acute exacerbations of multiple sclerosis: daily doses of 160 mg of triamcinolone for a week followed by 64 mg every other day for one month are recommended.
Local
Intra-articular administration: A single local injection of Kenacort® Retard is frequently sufficient, but several injections may be needed for adequate relief of symptoms.
Initial dose: 2.5 mg to 5 mg for smaller joints and from 5 mg to 15 mg for larger joints, depending on the specific disease entity being treated. For adults, doses up to 10 mg for smaller areas and up to 40 mg for larger areas have usually been sufficient. Single injections into several joints, up to a total of 80 mg, have been given.
Systemic
The initial dose may vary depending on the specific disease entity being treated. The range of initial doses is 0.11 to 1.6 mg/kg/day in 3 or 4 divided doses.
Kenacort® Retard is available in the following dosage forms and strengths:
In case of an emergency or an overdose, call your local emergency services or go to your nearest emergency room.
If you miss a dose of medication, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and take your regular dose as scheduled. Do not take a double dose.
Penafian
Hello Health Group tidak menawarkan nasihat perubatan, diagnosis atau rawatan.
Triamcinolone Injection Route. http://www.mayoclinic.org/drugs-supplements/triamcinolone-injection-route/description/drg-20074674. Accessed January 05, 2017.
Triamcinolone Injection Route. https://www.accessdata.fda.gov/drugsatfda_docs/anda/2009/090164Orig1s000.pdf. Accessed January 05, 2017.
Versi Terbaru
12/05/2020
Ditulis oleh Chan Tong
Disemak secara perubatan oleh Panel Perubatan Hello Doktor
Diperbaharui oleh: Nurul Nazrah Nazarudin
Disemak secara perubatan oleh
Panel Perubatan Hello Doktor